Literature DB >> 27139832

RRM domain of human RBM7: purification, crystallization and structure determination.

Nicholas Sofos1, Mikael B L Winkler1, Ditlev E Brodersen1.   

Abstract

RNA decay is an important process that is essential for controlling the abundance, quality and maturation of transcripts. In eukaryotes, RNA decay in the 3'-5' direction is carried out by the exosome, an RNA-degradation machine that is conserved from yeast to humans. A range of cofactors stimulate the enzymatic activity of the exosome and serve as adapters for the many RNA substrates. In human cells, the exosome associates with the heterotrimeric nuclear exosome targeting (NEXT) complex consisting of the DExH-box helicase hMTR4, the zinc-finger protein hZCCHC8 and the RRM-type protein hRBM7. Here, the 2.5 Å resolution crystal structure of the RRM domain of human RBM7 is reported. Molecular replacement using a previously determined solution structure of RBM7 was unsuccessful. Instead, RBM8 and CBP20 RRM-domain crystal structures were used to successfully determine the RBM7 structure by molecular replacement. The structure reveals a ring-shaped pentameric assembly, which is most likely a consequence of crystal packing.

Entities:  

Keywords:  NEXT complex; RNA degradation; RRM domain; X-ray crystallography; human

Mesh:

Substances:

Year:  2016        PMID: 27139832      PMCID: PMC4854568          DOI: 10.1107/S2053230X16006129

Source DB:  PubMed          Journal:  Acta Crystallogr F Struct Biol Commun        ISSN: 2053-230X            Impact factor:   1.056


  30 in total

Review 1.  The RNA recognition motif, a plastic RNA-binding platform to regulate post-transcriptional gene expression.

Authors:  Christophe Maris; Cyril Dominguez; Frédéric H-T Allain
Journal:  FEBS J       Date:  2005-05       Impact factor: 5.542

2.  RNA degradation by the exosome is promoted by a nuclear polyadenylation complex.

Authors:  John LaCava; Jonathan Houseley; Cosmin Saveanu; Elisabeth Petfalski; Elizabeth Thompson; Alain Jacquier; David Tollervey
Journal:  Cell       Date:  2005-06-03       Impact factor: 41.582

3.  Purification of eukaryotic exoribonucleases following heterologous expression in bacteria and analysis of their biochemical properties by in vitro enzymatic assays.

Authors:  Rafal Tomecki; Karolina Drazkowska; Antonina Krawczyk; Katarzyna Kowalska; Andrzej Dziembowski
Journal:  Methods Mol Biol       Date:  2015

4.  The yeast antiviral proteins Ski2p, Ski3p, and Ski8p exist as a complex in vivo.

Authors:  J T Brown; X Bai; A W Johnson
Journal:  RNA       Date:  2000-03       Impact factor: 4.942

5.  The 3' to 5' degradation of yeast mRNAs is a general mechanism for mRNA turnover that requires the SKI2 DEVH box protein and 3' to 5' exonucleases of the exosome complex.

Authors:  J S Anderson; R P Parker
Journal:  EMBO J       Date:  1998-03-02       Impact factor: 11.598

6.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

7.  Decision making in xia2.

Authors:  Graeme Winter; Carina M C Lobley; Stephen M Prince
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2013-06-18

8.  A new yeast poly(A) polymerase complex involved in RNA quality control.

Authors:  Stepánka Vanácová; Jeannette Wolf; Georges Martin; Diana Blank; Sabine Dettwiler; Arno Friedlein; Hanno Langen; Gérard Keith; Walter Keller
Journal:  PLoS Biol       Date:  2005-04-19       Impact factor: 8.029

9.  The Phyre2 web portal for protein modeling, prediction and analysis.

Authors:  Lawrence A Kelley; Stefans Mezulis; Christopher M Yates; Mark N Wass; Michael J E Sternberg
Journal:  Nat Protoc       Date:  2015-05-07       Impact factor: 13.491

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  1 in total

1.  Oncogenic action of the exosome cofactor RBM7 by stabilization of CDK1 mRNA in breast cancer.

Authors:  Pei-Wen Xi; Xu Zhang; Lei Zhu; Xin-Yuan Dai; Lin Cheng; Yue Hu; Liang Shi; Ji-Fu Wei; Qiang Ding
Journal:  NPJ Breast Cancer       Date:  2020-10-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.